Concentrix (NASDAQ:CNXC) Releases Q3 2026 Earnings Guidance

Concentrix (NASDAQ:CNXCGet Free Report) issued an update on its third quarter 2026 earnings guidance on Monday morning. The company provided EPS guidance of 2.650-2.770 for the period, compared to the consensus earnings per share estimate of 3.040. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 10.830-11.180 EPS.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CNXC shares. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Wall Street Zen cut shares of Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Concentrix in a research note on Monday, June 22nd. Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, March 25th. Finally, Robert W. Baird lowered their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $44.33.

Check Out Our Latest Report on CNXC

Concentrix Stock Up 0.9%

Shares of NASDAQ CNXC opened at $25.23 on Tuesday. The firm’s 50 day moving average price is $25.84 and its 200 day moving average price is $32.08. Concentrix has a 1 year low of $22.05 and a 1 year high of $62.14. The firm has a market cap of $1.54 billion, a P/E ratio of -1.17, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.18 and a current ratio of 1.18.

Concentrix (NASDAQ:CNXCGet Free Report) last released its earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.Concentrix’s revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the business posted $2.70 earnings per share. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, sell-side analysts anticipate that Concentrix will post 10.42 earnings per share for the current year.

Concentrix Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 5.7%. The ex-dividend date is Friday, July 24th. Concentrix’s dividend payout ratio is -6.68%.

Insider Transactions at Concentrix

In other news, CFO Andre S. Valentine bought 2,500 shares of the firm’s stock in a transaction dated Thursday, April 9th. The stock was bought at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the transaction, the chief financial officer owned 89,066 shares in the company, valued at $2,489,394.70. The trade was a 2.89% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider directly owned 2,773,667 shares in the company, valued at $61,714,090.75. This trade represents a 68.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.90% of the company’s stock.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Concentrix highlighted stronger cash generation in Q2, including record cash flow from operations and adjusted free cash flow, while also saying iX Suite deals rose sharply year over year. Concentrix Reports Second Quarter 2026 Results
  • Positive Sentiment: The company said it remains focused on AI-driven growth, offshore delivery shifts, and cost cuts to improve margins over time. Concentrix Q2 Earnings Call Focuses on AI Push, Margin Path
  • Neutral Sentiment: Concentrix declared a quarterly dividend of $0.36 per share, which supports the stock’s income appeal but is not a major near-term growth catalyst.
  • Neutral Sentiment: Market commentary noted CNXC among the day’s stock movers, reflecting broader investor attention to the earnings reaction and AI-related trading themes. Strategy, Super Micro, Concentrix, and More Stocks That Explain Today’s Market
  • Negative Sentiment: Q2 EPS of $2.63 missed expectations by a penny, and revenue of about $2.46 billion also came in slightly below estimates.
  • Negative Sentiment: Management cut both Q3 and full-year guidance below Wall Street forecasts, signaling pressure from softer client spending and a more cautious demand outlook. Concentrix cuts annual forecast as clients trim spend; shares fall

Hedge Funds Weigh In On Concentrix

Large investors have recently bought and sold shares of the stock. AQR Capital Management LLC lifted its position in Concentrix by 1.8% in the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after purchasing an additional 75,352 shares during the period. Dimensional Fund Advisors LP lifted its stake in Concentrix by 28.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock valued at $103,588,000 after purchasing an additional 551,778 shares during the last quarter. State Street Corp lifted its position in shares of Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after acquiring an additional 130,529 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Concentrix by 37.7% during the 4th quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock worth $33,509,000 after acquiring an additional 220,590 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Concentrix by 157.1% in the 4th quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after purchasing an additional 433,731 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Articles

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.